CF
CRGX

Corebridge Financial’s CARGO Therapeutics CRGX Stock Holding History

Corebridge Financial’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,820
Closed -$68.5K – 652
2025
Q1 		$68.5K Sell
16,820
-250
-1% -$1.67K ﹤0.01% 2622
2024
Q4 		$246K Sell
17,070
-1,288
-7% -$23.4K ﹤0.01% 2059
2024
Q3 		$339K Buy
18,358
+7,795
+74% +$139K ﹤0.01% 1927
2024
Q2 		$173K Buy
+10,563
New +$201K ﹤0.01% 2278

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return

Corebridge Financial's CRGX Position: Q2 2025 in Review

Corebridge Financial sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 16,820 shares — an estimated $68.5K sold.

Corebridge Financial first reported a position in CRGX in Q2 2024 and held it in 4 quarters. The position peaked at $339K in Q3 2024. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.

  • Corebridge Financial reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 16,820 CARGO Therapeutics shares in Q2 2025, an estimated $68.5K.
  • Corebridge Financial first reported a position in CARGO Therapeutics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's CARGO Therapeutics position peaked at $339K in Q3 2024.
  • 116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.